<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Monnie CM</submitter><funding>NIAID NIH HHS</funding><pagination>3417-3422</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12806166</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>366(16)</volume><pubmed_abstract>A scalable procedure for the synthesis of 4,6-difluorotryptophan is reported based on a deaminative coupling of a 4,6-difluorogramine with 2-benzylthio-1,5-dihydro-4&lt;i>H&lt;/i>-imidazolone as glycine equivalent. Thus prepared 4,6-difluorotryptophan was incorporated into the C-terminal domain of the HIV-1 capsid protein (CA-CTD), and &lt;sup>19&lt;/sup>F spectra of the 4,6-difluoro Trp CA CTD were recorded and compared to the singly fluorinated counterparts.</pubmed_abstract><journal>Advanced synthesis &amp; catalysis</journal><pubmed_title>Synthesis of 4,6-Difluoro-Tryptophan as a Probe for Protein &amp;lt;sup&amp;gt;19&amp;lt;/sup&amp;gt;F NMR.</pubmed_title><pmcid>PMC12806166</pmcid><funding_grant_id>U54 AI170791</funding_grant_id><pubmed_authors>Gronenborn AM</pubmed_authors><pubmed_authors>Hernandez I</pubmed_authors><pubmed_authors>Oiarbide M</pubmed_authors><pubmed_authors>Melendez-Pacheco R</pubmed_authors><pubmed_authors>Bhinderwala F</pubmed_authors><pubmed_authors>Landa A</pubmed_authors><pubmed_authors>Monnie CM</pubmed_authors><pubmed_authors>Soloshonok VA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Synthesis of 4,6-Difluoro-Tryptophan as a Probe for Protein &amp;lt;sup&amp;gt;19&amp;lt;/sup&amp;gt;F NMR.</name><description>A scalable procedure for the synthesis of 4,6-difluorotryptophan is reported based on a deaminative coupling of a 4,6-difluorogramine with 2-benzylthio-1,5-dihydro-4&lt;i>H&lt;/i>-imidazolone as glycine equivalent. Thus prepared 4,6-difluorotryptophan was incorporated into the C-terminal domain of the HIV-1 capsid protein (CA-CTD), and &lt;sup>19&lt;/sup>F spectra of the 4,6-difluoro Trp CA CTD were recorded and compared to the singly fluorinated counterparts.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Aug</publication><modification>2026-06-06T13:48:24.342Z</modification><creation>2026-05-31T03:09:56.424Z</creation></dates><accession>S-EPMC12806166</accession><cross_references><pubmed>41552695</pubmed><doi>10.1002/adsc.202400031</doi></cross_references></HashMap>